Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease.
Hopkins
W E
WE
Cardiology Unit, University of Vermont College of Medicine, Burlington, Vermont, USA.
Kelly
D P
DP
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use*; D003490:Cyanosis; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications / Q000503:physiopathology*; D006331:Heart Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D018754:Ventricular Dysfunction / Q000503:physiopathology
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D002216:Captopril